These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19850418)

  • 1. [Breast cancer screening imaging: what do we do].
    Balu-Maestro C; Chapellier C; Souci J; Caramella T; Marcotte-Bloch C
    J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):3-10. PubMed ID: 19850418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Breast Cancer.
    Niell BL; Freer PE; Weinfurtner RJ; Arleo EK; Drukteinis JS
    Radiol Clin North Am; 2017 Nov; 55(6):1145-1162. PubMed ID: 28991557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening in women: An integrative literature review.
    Ravert PK; Huffaker C
    J Am Acad Nurse Pract; 2010 Dec; 22(12):668-73. PubMed ID: 21129075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the frontline of screening for breast cancer.
    D'Orsi CJ; Newell MS
    Semin Oncol; 2011 Feb; 38(1):119-27. PubMed ID: 21362520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of breast imaging to screen women at high risk for cancer.
    Sickles EA
    Radiol Clin North Am; 2010 Sep; 48(5):859-78. PubMed ID: 20868890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
    J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACR Appropriateness Criteria Breast Cancer Screening.
    Mainiero MB; Lourenco A; Mahoney MC; Newell MS; Bailey L; Barke LD; D'Orsi C; Harvey JA; Hayes MK; Huynh PT; Jokich PM; Lee SJ; Lehman CD; Mankoff DA; Nepute JA; Patel SB; Reynolds HE; Sutherland ML; Haffty BG
    J Am Coll Radiol; 2013 Jan; 10(1):11-4. PubMed ID: 23290667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
    Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
    J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored supplemental screening for breast cancer: what now and what next?
    Berg WA
    AJR Am J Roentgenol; 2009 Feb; 192(2):390-9. PubMed ID: 19155400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging.
    Pederson HJ; O'Rourke C; Lyons J; Patrick RJ; Crowe JP; Grobmyer SR
    Clin Breast Cancer; 2015 Oct; 15(5):348-52. PubMed ID: 25749071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tailored breast cancer screening with ultrasound and MRI?].
    van Gils CH; Veldhuis W; Peeters P
    Ned Tijdschr Geneeskd; 2012; 156(37):A5313. PubMed ID: 22971434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Revised practice guideline 'Screening and diagnosis of breast cancer'].
    Zonderland HM; Tuut MK; den Heeten GJ; Asperen CJ; de Bock GH; Rutqers EJ; Westenend PJ; Smit GM; Benraadt J
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2336-9. PubMed ID: 19024064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New developments in breast imaging].
    Tardivon A; el Khoury C; Thibault F; Meunier M
    Cancer Radiother; 2004 Feb; 8(1):2-8. PubMed ID: 15093195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to follow-up women with dense breasts by imaging?].
    Tardivon A
    J Radiol; 2008 Sep; 89(9 Pt 2):1204-8. PubMed ID: 18772805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Organized or individual breast cancer screening: what motivates women?].
    Kalecinski J; Régnier-Denois V; Ouédraogo S; Dabakuyo-Yonli TS; Dumas A; Arveux P; Chauvin F
    Sante Publique; 2015; 27(2):213-20. PubMed ID: 26414035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of MRI imaging in patients with breast cancer].
    Mooyaart EA; Veltman J; Boetes C; Blickman JG
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1521-7. PubMed ID: 16032998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.